Intranasal Insulin Reduces White Matter Hyperintensity Progression in Association with Improvements in Cognition and CSF Biomarker Profiles in Mild Cognitive Impairment and Alzheimer’s Disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2426-0266
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Intranasal Insulin Reduces White Matter Hyperintensity Progression in Association with Improvements in Cognition and CSF Biomarker Profiles in Mild Cognitive Impairment and Alzheimer’s Disease ; day:7 ; month:4 ; year:2021 ; pages:1-9
The journal of prevention of Alzheimer's disease ; (7.4.2021), 1-9
- Urheber
-
Kellar, D.
Lockhart, S. N.
Aisen, P.
Raman, R.
Rissman, R. A.
Brewer, J.
Craft, Suzanne
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.14283/jpad.2021.14
- URN
-
urn:nbn:de:101:1-2021060118450580974399
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:43 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kellar, D.
- Lockhart, S. N.
- Aisen, P.
- Raman, R.
- Rissman, R. A.
- Brewer, J.
- Craft, Suzanne
- SpringerLink (Online service)
Ähnliche Objekte (12)
Intranasal Insulin for Alzheimer’s Disease
CSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer’s disease
CSF Presenilin-1 complexes are increased in Alzheimer’s disease
Alzheimer’s disease CSF biomarkers: clinical indications and rational use
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
Brainstem substructures and cognition in prodromal Alzheimer’s disease
Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease
Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer’s mice
Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum
CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease
Disease staging of Alzheimer’s disease using a CSF-based biomarker model
CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease
Intranasal Insulin for Alzheimer’s Disease
CSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer’s disease
CSF Presenilin-1 complexes are increased in Alzheimer’s disease
Alzheimer’s disease CSF biomarkers: clinical indications and rational use
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
Brainstem substructures and cognition in prodromal Alzheimer’s disease
Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease
Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer’s mice
Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum
CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease
Disease staging of Alzheimer’s disease using a CSF-based biomarker model
CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease
Intranasal Insulin for Alzheimer’s Disease
CSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer’s disease
CSF Presenilin-1 complexes are increased in Alzheimer’s disease
Alzheimer’s disease CSF biomarkers: clinical indications and rational use
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
Brainstem substructures and cognition in prodromal Alzheimer’s disease
Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease
Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer’s mice
Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum
CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease
Disease staging of Alzheimer’s disease using a CSF-based biomarker model